Gadolinium-160 Market Share Driven by Growth in Medical Imaging and Nuclear Applications | Valuates Reports

Gadolinium-160 Market Size
The global market for Gadolinium-160 was valued at US$ 4.4 million in the year 2024 and is projected to reach a revised size of US$ 7.1 million by 2031, growing at a CAGR of 7.2% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-28U3070/Global_Gadolinium_Market_Insights_and_Forecast_to_2028

The Gadolinium-160 market is experiencing robust growth, driven by increasing demand in medical imaging, nuclear reactors, materials science, and research applications. Its unique nuclear properties and versatility in high-precision applications make it a critical material for both healthcare and scientific sectors. Growing investments in advanced medical imaging technologies, nuclear energy infrastructure, and materials research are shaping market trends and contributing to overall market growth.

Among production types, nuclear reactor irradiation currently holds the largest market share, due to its established use in producing high-purity Gadolinium-160 for medical and nuclear applications. Isotope separation production is expanding rapidly, offering precise control over isotopic composition, which is increasingly important for specialized research and industrial applications. Both methods support the market's growth by meeting diverse production requirements.

In application terms, medical imaging remains the leading segment, driven by the need for enhanced imaging contrast and diagnostic accuracy. Nuclear reactors also represent a significant segment, where Gadolinium-160 is used for neutron absorption and reactor safety. Materials science and research applications are growing steadily as innovations in material engineering and experimental studies continue to expand the isotope's use.

Key companies in the Gadolinium-160 market include NIDC, Rosatom, Neonest AB (BuyIsotope), CortecNet, Kinectrics, Eurisotop, Clearsynth, EvitaChem, and American Elements. These organizations lead through advanced production capabilities, strategic collaborations, and innovations in isotope processing. Their initiatives in ensuring high-purity, reliable supply and expanding applications are central to maintaining market share and driving growth globally.

Regionally, North America dominates the Gadolinium-160 market, supported by strong healthcare infrastructure, research institutions, and nuclear facilities. Europe also holds a significant position with adoption in both medical and nuclear sectors. The Asia-Pacific region, particularly China and Japan, is witnessing rapid market growth, driven by industrial development, healthcare expansion, and increasing investments in research and nuclear technology. The market forecast indicates continued expansion, fueled by technological innovations, increased adoption in healthcare and research, and regulatory support for nuclear and medical applications.

Segment by Type

• Nuclear Reactor Irradiation Production
• Isotope Separation Production

Segment by Application

• Medical Imaging
• Nuclear Reactors
• Materials Science
• Research Applications

By Company

NIDC, Rosatom, Neonest AB(BuyIsotope), CortecNet, Kinectrics, Eurisotop, Clearsynth, EvitaChem, American Elements

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-28U3070/global-gadolinium

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.